Publisher: "EDITORY-PRESS" LLC

Language: English

First Publication: 2026

Publication Frequency: Quarterly

Publication Format: Online / Electronic

Specialization: Scientific, medical and biological sciences

ISSN: Pending

Access Model: Gold Open Access

Article Processing Charge (APC): No article processing charges are currently required.

Copyright: Authors retain copyright ownership of their work.

License: Creative Commons Attribution (CC BY), allowing redistribution, reuse, adaptation and commercial use with appropriate attribution.

Peer Review Model: Single-anonymized peer review

Submissions are initially assessed by the editors for suitability. Manuscripts that proceed to peer review are typically evaluated by at least two independent expert reviewers.

Editorial Decisions:

• Accept
• Minor Revision
• Major Revision
• Reject

The Editor-in-Chief has final authority over editorial decisions.

• Original Research Articles
• Review Articles
• Short Communications
• Case Reports
• Methods and Protocols
• Letters to the Editor

Clinical & Molecular Biomedicine focuses on translational biomedical research integrating molecular biology, clinical medicine and emerging biomedical technologies.

• Translational medicine
• Molecular and cellular biology
• Clinical biochemistry
• Genomics and epigenetics
• Proteomics and metabolomics
• Microbiome research
• Molecular oncology
• Neurobiology
• Biomarker discovery
• Drug discovery and resistance
• Gene and cell therapy
• Precision medicine
• Immunology and vaccinology

The journal follows internationally recognized publication ethics guidelines, including:

• Committee on Publication Ethics (COPE)
• International Committee of Medical Journal Editors (ICMJE)
• World Association of Medical Editors (WAME)

Authors are expected to ensure originality, accurate reporting, proper citation, absence of plagiarism or duplicate publication, and appropriate ethical approval for human and animal research.